Pggm Investments’s Abbott Laboratories Position
Does Pggm Investments own Abbott Laboratories (ABT)? Yes — 810.1K shares worth $83M (+1.46% of its 13F portfolio) as of Q1 2026.
Position Value
$83M
Q1 2026
Shares
810.1K
% of Portfolio
+1.46%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 810.1K | $83M | +1.46% |
| Q4 2025 | 810.1K | $101M | +1.61% |
| Q3 2025 | 810.1K | $108M | +1.76% |
| Q2 2025 | 844.3K | $115M | +1.99% |
| Q1 2025 | 659.7K | $88M | +1.18% |
| Q4 2024 | 680.0K | $77M | +1.02% |
| Q3 2024 | 658.5K | $75M | +0.96% |
| Q2 2024 | 649.1K | $67M | +0.97% |
| Q1 2024 | 649.2K | $74M | +1.07% |
| Q4 2023 | 648.0K | $71M | +1.09% |
| Q3 2023 | 265.0K | $26M | +0.44% |
| Q2 2023 | 298.8K | $33M | +0.53% |
| Q1 2023 | 320.6K | $32M | +0.55% |
| Q4 2022 | 281.9K | $31M | +0.54% |
| Q3 2022 | 279.9K | $27M | +0.48% |
| Q1 2022 | 605.7K | $85M | +0.42% |
| Q4 2021 | 605.7K | $85M | +0.42% |
| Q3 2021 | 663.3K | $78M | +0.40% |
| Q2 2021 | 691.8K | $80M | +0.34% |
| Q1 2021 | 750.2K | $90M | +0.39% |
| Q4 2020 | 916.6K | $100M | +0.46% |
| Q3 2020 | 1.25M | $136M | +0.71% |
| Q2 2020 | 1.28M | $117M | +0.68% |
| Q1 2020 | 1.09M | $86M | +0.62% |
| Q4 2019 | 225.7K | $20M | +0.11% |
| Q3 2019 | 225.7K | $19M | +0.09% |
| Q2 2019 | 225.7K | $19M | +0.10% |
| Q1 2019 | 225.7K | $18M | +0.09% |
| Q4 2018 | 319.7K | $23M | +0.13% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pggm Investments’s full portfolio or all institutional holders of ABT.